Sun Hao-Jia, Zheng Zhui-Feng, Zhang Li-Jun, Fang Le, Fu Hua, Chen Shao-Yang, Feng Rong-Xiu, Liu Xiao-Yang, Tang Qing-Nan, Liu Xue-Wen
Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
Department of Breast Medical Oncology, Fujian Cancer Hospital and the Fujian Medical University Cancer Hospital, Fuzhou, 350014, Fujian, China.
Discov Oncol. 2024 Jul 29;15(1):314. doi: 10.1007/s12672-024-01190-y.
To assess the infiltration characteristics of tumour-associated macrophages (TAMs) in buccal mucosa carcinoma (BMC) and the correlation of these features with clinicopathological factors.
Immunohistochemistry was used to detect the expression of TAM-related markers (CD68, CD163, CD206), CD8+ T cell markers, PD-L1, and epidermal growth factor receptor (EGFR) in 46 patients with mucosal cancer after radical surgery. In addition, the correlation between TAM infiltration and clinical characteristics, PD-L1 expression, and EGFR expression was analysed.
A high infiltration level of M2-polarized (CD206+) TAMs and M2-polarized (CD163+) TAMs was more common in stage T3-T4, N+, III-IV patients than in other patient groups (P < 0.05). The infiltration degree of M2-polarized (CD68+) TAMs was positively correlated with the PD-L1 TPS (P = 0.0331). The infiltration level of M2-polarized (CD206+) TAMs was higher in the EGFR high expression group than in the EGFR low expression group (P = 0.040).
High infiltration of M2-polarized TAMs is highly associated with advanced disease stage and higher expression of PD-L1 and EGFR in BMCs, suggesting that M2-polarized TAMs infiltration can serve as a potential therapeutic target.
评估肿瘤相关巨噬细胞(TAM)在颊黏膜癌(BMC)中的浸润特征以及这些特征与临床病理因素的相关性。
采用免疫组织化学法检测46例接受根治性手术的黏膜癌患者中TAM相关标志物(CD68、CD163、CD206)、CD8 + T细胞标志物、程序性死亡受体配体1(PD-L1)和表皮生长因子受体(EGFR)的表达。此外,分析TAM浸润与临床特征、PD-L1表达及EGFR表达之间的相关性。
M2极化(CD206 +)TAM和M2极化(CD163 +)TAM的高浸润水平在T3-T4期、N +、III-IV期患者中比其他患者组更常见(P < 0.05)。M2极化(CD68 +)TAM的浸润程度与PD-L1肿瘤比例评分(TPS)呈正相关(P = 0.0331)。EGFR高表达组中M2极化(CD206 +)TAM的浸润水平高于EGFR低表达组(P = 0.040)。
M2极化TAM的高浸润与BMC的疾病晚期以及PD-L1和EGFR的高表达高度相关,提示M2极化TAM浸润可作为潜在的治疗靶点。